Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
AusCann Group Holdings Ltd (ASX: AC8) - Share Price and Research
- Current share price for AC8 : $0.040
AusCann Group Holdings Ltd (AC8, formerly TW Holdings Limited), an ASX-listed company, is a Perth-based company engaged in the development of a stable, reliable dose form cannabinoid pharmaceutical product and preparing for its clinical trials. The country of operation is Australia and Chile.
AC8 General Information +
| ASX Code | AC8 |
| Website | http://www.auscann.com.au |
| Industry/Sector | Pharmaceuticals |
| Market Cap ($M) | 17 |
| AC8 Share Price | $0.040 |
| Day High | $0.000 |
| Day Low | $0.000 |
| Last Close | $0.040 |
| AC8 Share Price Movement | - ( No change ) |
Prices as at 16:40, 19 Apr 2024
+Security prices are delayed by at least 20 minutes and are indicative only.
AC8 Related Research
AusCann Group Holdings Ltd (AC8) Upcoming Dividends & Yields
There are no dividends for AusCann Group Holdings Ltd (AC8). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
AusCann Group Holdings Ltd (AC8) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Half Yearly Report and Accounts | 3 Apr 2024 6:26PM | $0.040 | $0.040 | $0.040 | fallen by 0% |
| Cancel - Proposed issue of securities - AC8 | 15 Feb 2024 4:07PM | $0.040 | $0.040 | $0.040 | fallen by 0% |
| Supplementary Prospectus | 15 Feb 2024 3:19PM | $0.040 | $0.040 | $0.040 | fallen by 0% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from AusCann Group Holdings Ltd (AC8) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
AC8 Financial Summary
| Year to Jun | NPAT | EPS | EPS chg (%) | PER | DPS | Yield (%) | Franking (%) |
|---|---|---|---|---|---|---|---|
| 2023A | -$0.89 | -$0.20 | -82.00% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2022A | -$4.87 | -$1.10 | -58.40% | 0.00 | 0.00 | 0.00% | 0.0% |
| 2021A | -$9.40 | -$2.70 | 31.50% | 0.00 | 0.00 | 0.00% | 0.0% |
AC8 Peer Comparison
| Company | Mkt Cap | EPS Growth (%) | P/E (%) | Dividend Yield (%) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | 2021 A | 2022 A | 2023 A | ||
| AusCann Group Holdings (AC8) | $18M | -0.8198 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Mayne Pharma Group (MYX) | $574M | 0.9287 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.00% | 0.00% | 0.00% |
| Neuren Pharmaceuticals (NEU) | $2,512M | 799.6667 | -0.5504 | 0.6667 | 16.3780 | 36.4259 | 21.8556 | 0.00% | 0.00% | 0.00% |
AC8 Market Comparison
| Earnings | P/E Ratio | P/B Ratio | P/E Growth | |
|---|---|---|---|---|
| Company | 0.00 | 0.00 | 1.03 | 0.00 |
| Market | 0.53 | 15.00 | 1.10 | 1.00 |
| Sector | 1.26 | 21.10 | 1.96 | 0.95 |
AC8 Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Andrew Chapman | Non-Executive Chairman, Non-Executive Director | 1 Dec 2023 |
| Mr Robert Clifford | Non-Executive Director | 1 Apr 2021 |
| Mr Brett Anthony Mitchell | Non-Executive Director | 29 Jun 2023 |
AusCann Group Holdings Ltd (AC8) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 4 Nov 2021 | BATES, Krista | Transfer | Direct Shares | 427,500 | $0.103 | $44,000.000 |
| 4 Nov 2021 | BATES, Krista | Transfer | Indirect Shares | 427,500 | $0.103 | $44,000.000 |
| 14 May 2021 | STARR, Geoff | Buy | Direct Shares | 100,000 | $0.115 | $11,500.000 |
See all changes in directors' interest & trades for AusCann Group Holdings Ltd (AC8) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
AC8 Management
| Name | Position |
|---|---|
| Layton Patrick Mills | Chief Executive Officer |
| Quentin Heath Megson | Chief Financial Officer,Joint Company Secretary |
| Rachel Kerr | Company Secretary |
AC8 Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in AusCann Group Holdings Ltd (AC8). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 72,223,727 (16.39%) | Merchant Funds Management Pty Ltd |
AC8 Calendar of Events
| Date | Event |
|---|---|
| 02 April 2025 | Report (Interim) |
| 25 October 2024 | Report (Annual) |
| 29 August 2024 | Report (Prelim) |
FAQs about AusCann Group Holdings Ltd (AC8)
What is the current share price of AusCann Group Holdings Ltd (AC8)?
AusCann Group Holdings Ltd's (AC8) current share price is $0.04. This constitutes a price movement of 0% when compared to the share price 7 days ago and is 0% below AC8's 12-month high of $0.04 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for AusCann Group Holdings Ltd (AC8)?
Relative to the previous close share price of $0.04, AusCann Group Holdings Ltd's (AC8) current share price of $0.04 constitutes a movement of or 0%. AusCann Group Holdings Ltd's (AC8) share price movement is 0% when compared to 7 days ago and is 0% below AC8's 52-week high of $0.04.
What is the 52-week high share price for AusCann Group Holdings Ltd (AC8)?
AusCann Group Holdings Ltd's (AC8) 52-week high is $0.04 which was reached on 21 Apr 2023. Relative to this, AC8's current share price of $0.04 constitutes a or 0% drop since that high of $0.04 per AC8 share.
What is the 52-week low share price for AusCann Group Holdings Ltd (AC8)?
AusCann Group Holdings Ltd's (AC8) 52-week low is $0.04 which was reached on 21 Apr 2023. Relative to this, AC8's current share price of $0.04 constitutes a or 0% drop since that low of $0.04 per AC8 share.
What is the daily average trading volume for AusCann Group Holdings Ltd (AC8)?
Over the last 12 months, AusCann Group Holdings Ltd (AC8) has a daily average trading volume of 0 AC8 shares per day.
What is the dividend yield for AusCann Group Holdings Ltd (AC8)?
AusCann Group Holdings Ltd (AC8) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for AC8 is a ratio that tells you the percentage of AusCann Group Holdings Ltd's (AC8) share price that it pays out in dividends each year.
When does AusCann Group Holdings Ltd (AC8) release its next Annual Report?
AusCann Group Holdings Ltd (AC8) will release its next Annual Report on 25 October 2024. AusCann Group Holdings Ltd's (AC8) last annual report was released on 27 Oct 2023. Click here to view AusCann Group Holdings Ltd's (AC8) last annual report.
In which sector is AusCann Group Holdings Ltd (AC8) classified?
AusCann Group Holdings Ltd (AC8) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Cochlear Limited (COH), ResMed Inc. (RMD), and Fisher & Paykel Healthcare Corporation Limited (FPH).
What is the price-to-earnings (P/E) ratio for AusCann Group Holdings Ltd (AC8)?
The price-to-earnings (P/E) ratio for AusCann Group Holdings Ltd (AC8) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of AusCann Group Holdings Ltd's (AC8) share price to its earnings per AC8 share.
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
